Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 2/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.36 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.35 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28751868 | 0.75 | ACACB (0.42) | MAPTALDH1A1ACACBNPC1EGFR | |
| SCHEMBL27461055 | 0.75 | MEN1 (0.37) | MAPTALDH1A1NPC1GAARAB9A | |
| SCHEMBL27771143 | 0.74 | PIN1 (0.57) | ALDH1A1NPC1PIN1RAB9A | |
| SCHEMBL28122016 | 0.74 | MEN1 (0.33) | ACACBMAP3K7TAB1 | |
| SCHEMBL27599363 | 0.73 | ALOX5 (0.45) | MAPTALDH1A1P4HTMPARP10ALOX5 | |
| SCHEMBL27617777 | 0.73 | ALDH1A1 (0.41) | MAPTALDH1A1NPC1EGFRERBB2 | |
| SCHEMBL27884312 | 0.72 | KDM4E (0.33) | ALDH1A1 | |
| SCHEMBL28091717 | 0.69 | KDM4E (0.32) | ALDH1A1 | |
| SCHEMBL27730833 | 0.69 | ALOX5 (0.46) | ACACBP4HTMEGFRPARP10LTA4H | |
| SCHEMBL28093088 | 0.68 | NPC1 (0.45) | MAPTALDH1A1NPC1PARP10RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101380297-A | Compound platinum medicine sustained-release agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2009-03-11 | — | — | CN | claimed |
| CN-101254170-A | An anticancer sustained release injection carrying clorfarabine and its synergist | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2008-09-03 | — | — | CN | claimed |
| CN-101244034-A | Sustained-release agent containing taxone and its synergistic agent | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2008-08-20 | — | — | CN | claimed |
| CN-101023922-A | Anti-cancer sustained-release agent carrying glucocorticoid hormone and chemotherapeutic drug | KANGQUAN MEDICINE SCIENCE TECH (CN) | 2007-08-29 | — | — | CN | claimed |
| CN-101002730-A | Compounding anticarcinogen containing neovascular-inhibitor | SHUAIHUA MEDICAL TECH CO LTD J (CN) | 2007-07-25 | — | — | CN | claimed |
| CN-1973823-A | Anticancer composition containing Synergist | SHANDONG LANJIN BIOENGINEERING (CN) | 2007-06-06 | — | — | CN | claimed |
| CN-1969816-A | Anticancer sustained-release agent containing epothilone | JINAN SHUAIHUA MEDICAL TECHNOL (CN) | 2007-05-30 | — | — | CN | claimed |
| CN-1957910-A | Anti cancer controlled release formulation of containing consubstantial hydrolytic agent | LANJIN BIOENGINEERING CO LTD S (CN) | 2007-05-09 | — | — | CN | claimed |
| CN-1927174-A | Anticancer slow release injection loading tetrazole violet and potentiating agent thereof | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2007-03-14 | — | — | CN | claimed |
| CN-1923171-A | Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2007-03-07 | — | — | CN | claimed |
| CN-1875934-A | Anticancer drug sustained-release injection carrying clorfarabine and synergist thereof | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1861050-A | Anticancer drug sustained-release injection loaded with platinum compound and synergist thereof | LANJIN BIOENGINEERING CO LTD S (CN) | 2006-11-15 | — | — | CN | claimed |
| CN-1861047-A | Slow-releasing injection contg. vasoinhibitor and potentiator type anticarcinogen | SHUAIHUA MEDICINE SCIENCE AND (CN) | 2006-11-15 | — | — | CN | claimed |
| CN-1861049-A | Anticancer drug sustained-release injection containing gemcitabine | LANJIN BIOENGINEERING CO LTD S (CN) | 2006-11-15 | — | — | CN | claimed |
| CN-1850039-A | Compound platinum medicine slow-release agent | SHUAIHUA MEDICINE SCIENCE TECH (CN) | 2006-10-25 | — | — | CN | claimed |
| CN-1846679-A | Sustained-release injection containing methotrexate and synergist thereof | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | claimed |
| CN-1846676-A | Sustained-release injection containing fluorouracil synergist and preparation method thereof | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | claimed |
| CN-1846673-A | Slow-released anticancer medicine prepn containing pyrimidine medicine | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | claimed |
| CN-1846687-A | Slow-release agent containing taxane and synergist thereof | JINAN KANGQUAN MEDICINE SCI TE (CN) | 2006-10-18 | — | — | CN | claimed |
| CN-1628853-A | Anti-cancer medicine composition | KONG QINGZHONG (CN) | 2005-06-22 | — | — | CN | claimed |